U.S. Tech Hardware Stock News

In recent weeks, Parker-Hannifin has attracted a wave of favorable analyst attention, with several major firms initiating or reaffirming positive ratings that highlight its role in motion and control technologies across industrial and aerospace markets. This concentration of upbeat research coverage underscores how Wall Street currently views Parker-Hannifin as a key beneficiary of demand for automation, electrification, and aerospace systems, supported by its history of integrating...

Barclays’ new coverage of Ryman Hospitality Properties (RHP), together with a Fitch credit upgrade and a fresh cash dividend declaration, has put this hotel and entertainment REIT squarely on income focused investors’ radar. See our latest analysis for Ryman Hospitality Properties. At a share price of $94.10, Ryman’s recent news flow has arrived alongside a 90 day share price return of 6.16%, while the 1 year total shareholder return of 4.84% decline contrasts with a much stronger 3 year...

If you are wondering whether Byrna Technologies at around US$17.50 is a bargain or already pricing in a lot of optimism, you are in the right place. The stock has been through a mixed patch, with a 1.4% gain over the last week, an 11.0% decline over the past month, a 4.7% gain year to date, a 35.3% decline over the past year, and a 94.4% gain over three years that leaves the five year return at 25.0%. These swings have kept Byrna Technologies on the radar of investors watching how sentiment...

Xylem (XYL) is back in focus as investors look ahead to its upcoming fiscal fourth quarter 2025 earnings report, with analysts projecting profit of $1.41 per diluted share, which implies 19.5% growth. See our latest analysis for Xylem. The recent 1 day share price return of 1.68% and 7 day share price return of 2.72% put Xylem at US$141.33, although the 90 day share price return of 4.63% suggests momentum has cooled, while the 1 year total shareholder return of 23.53% points to a stronger...

Array Technologies recently promoted Darin Green to Global Chief Revenue Officer and Nick Strevel to Chief Product Officer, expanding their responsibilities over worldwide revenue generation and product development functions, including Product Management, Technical Sales, and Applications Engineering. These leadership moves underscore Array’s effort to tighten the link between customer needs and its product roadmap while driving more coordinated global sales execution. We’ll now examine how...

If you are wondering whether Amkor Technology's current share price lines up with its real worth, this article will walk through what the numbers say and where valuation checks are pointing. The stock last closed at US$51.29, with returns of 27.0% over 7 days, 18.6% over 30 days, 19.5% year to date, 95.9% over 1 year, 84.1% over 3 years and 211.0% over 5 years. This naturally raises questions about how its recent performance lines up with underlying value. Recent coverage around Amkor has...

Recent commentary around DocuSign (DOCU) centers on softer annual recurring revenue growth of 8.4% and forecasts for roughly 6.7% growth, which have raised fresh questions about long-term demand and customer commitment. See our latest analysis for DocuSign. Those concerns around softer annual recurring revenue growth are showing up in the share price, with DocuSign trading at US$65.19 after a 1 day share price return of 1.32% but a 1 year total shareholder return decline of 26.14%, suggesting...

If you are wondering whether Olema Pharmaceuticals at around US$25.04 is offering fair value today, you are not alone; this article is set up to help you weigh what that price might actually represent. The stock has had a very large 1 year return of 335.5%. However, the last 30 days show a 10.5% decline and the year to date return sits around 0.9%, which can change how investors think about both upside and risk. Recent headlines around Olema have focused on its position within the...

HEICO (HEI) has been drawing attention after reporting record results across multiple recent quarters. These results have been supported by organic growth, acquisitions in its Flight Support and Electronic Technologies groups, and a growing missile defense order backlog. See our latest analysis for HEICO. At a share price of $347.7, HEICO has seen firm upward momentum recently, with a 30-day share price return of 11.37% and a 1-year total shareholder return of 54.06%, pointing to strong...

If you are wondering whether Ecolab’s current share price really matches what you are getting as an investor, this article walks through the key numbers so you can judge value for yourself. Ecolab’s stock recently closed at US$271.53, with returns of 2.7% over 7 days, 4.6% over 30 days, 3.4% year to date, 18.5% over 1 year, 84.2% over 3 years and 28.5% over 5 years that many investors may want to put in context. Recent news coverage around Ecolab has largely focused on its role in water,...

Euna Solutions previously announced that its Euna Marketplace, a Workday Certified Integration tailored for public-sector procurement, is now available on the Workday Marketplace, allowing Workday users to shop approved supplier catalogs within Euna’s AI-enabled platform and complete purchases back in Workday. This deeper connection between Workday and a specialized public-sector procurement platform underscores how Workday’s ecosystem approach can extend its applications into regulated,...

Today we're going to take a look at the well-established Warner Music Group Corp. ( NASDAQ:WMG ). The company's stock...

Insiders who bought US$3.82m worth of Mercer International Inc. ( NASDAQ:MERC ) stock in the last year have seen some...

Anyone interested in Rapport Therapeutics, Inc. ( NASDAQ:RAPP ) should probably be aware that the Founder & Chief...

If you are wondering whether Ellington Financial at around US$13.53 is offering good value today, you are not alone. This article is designed to walk you through that question step by step. The stock has had a mixed short term run, with returns of a 1.6% decline over 7 days, a 1.4% decline over 30 days and a 1.1% decline year to date. The longer term picture shows 24.4% over 1 year, 51.1% over 3 years and 62.1% over 5 years. Recent attention on Ellington Financial has centered around its...

Lennox International (LII) is back in focus after weaker Q3 results, with year-on-year revenue declines, an earnings miss, and management describing 2025 as a transitional year shaped by refrigerant changes and tougher macroeconomic conditions. See our latest analysis for Lennox International. The share price has been volatile around these updates, with a 3.2% 1 day share price return and 5.2% 7 day share price return, but a 6.3% 90 day share price decline and a 14.1% 1 year total shareholder...

Why Darden’s updated outlook caught investors’ attention Darden Restaurants (DRI) lifted its full year sales guidance after reporting steady demand across its brands, especially Olive Garden, and pointing to market share gains versus both casual dining peers and limited service rivals. See our latest analysis for Darden Restaurants. The updated outlook comes on top of a recent run in the shares, with a 30 day share price return of 12.68% and a 1 year total shareholder return of 11.92%. This...

You might be wondering whether Altria Group's current share price still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$55.16, with recent returns of a 4.5% decline over 7 days, a 4.9% decline over 30 days, a 3.8% decline year to date, a 14.9% gain over 1 year, a 52.3% gain over 3 years and a 99.0% gain over 5 years. Recent attention around Altria Group has focused on its position in the tobacco and nicotine market and how its product mix...

UMB Financial (UMBF) is back in focus after fresh data highlighted strong market share gains, a 17.8% annual rise in net interest income over five years and 20.4% annual earnings per share growth. See our latest analysis for UMB Financial. The recent fundamentals story has been met with a firmer share price, with UMB Financial now at $121.43 after a 5.65% 1 month share price return and a 72.74% 5 year total shareholder return. This suggests momentum has been building over time. If you are...

If you are wondering whether Pool's share price still reflects its underlying business, you are not alone. This article focuses on what the numbers say about value rather than short term excitement. Pool closed at US$239.38, with returns of 3.6% over the last 7 days, roughly flat at a 0.1% decline over 30 days, a 4.2% gain year to date, and longer term share price declines of 25.8% over 1 year, 23.3% over 3 years, and 34.1% over 5 years. These moves are set against a backdrop of ongoing...

If you have been wondering whether Baidu’s recent run makes it expensive or still interesting, this article will walk through what the current share price actually bakes in. The stock closed at US$146.42, with returns of 10.6% over the last 7 days, 16.5% over the last 30 days, and 77.2% over the last year. Year to date it is at a 2.6% decline, and the 5-year return sits at a 38.9% decline. These price moves sit against an ongoing stream of headlines around Chinese technology companies and...

Powell Industries (POWL) has drawn fresh attention after its shares moved 10.6% higher on the first U.S. trading day of 2026, with investors positioning in advance of an early February earnings update. See our latest analysis for Powell Industries. The early year move has come on top of a 9.9% 7 day share price return and a 14.1% 90 day share price return, while the 1 year total shareholder return of 52.5% and very large 3 and 5 year total shareholder returns suggest that momentum has been...

If you have been wondering whether Abbott Laboratories at around US$127.78 is offering fair value or a premium price, this breakdown is designed to give you a clear and structured view. The stock has recorded returns of 1.6% over the last 7 days, 2.2% over the last 30 days, 2.9% year to date, 14.8% over 1 year, 19.0% over 3 years, and 28.5% over 5 years, which many investors will weigh against current pricing. Recent attention on Abbott has centered on how its broad healthcare portfolio and...

Stock performance snapshot and business profile Evolv Technologies Holdings (EVLV) has been drawing attention after recent trading moves, with the stock showing mixed short term returns, including gains over the past month alongside a decline over the past 3 months. The US based security technology company focuses on AI driven weapons detection systems for venues such as schools, hospitals, sports arenas, entertainment sites and industrial workplaces, supported by products like Evolv Express...